Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SALL4: An Intriguing Therapeutic Target in Cancer Treatment. | Cells | 2022 | 36010677 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer. | Cells | 2022 | 36010585 | PubTator, text mining | PubMed |
| FPocketWeb: protein pocket hunting in a web browser. | J Cheminform | 2022 | 36008829 | PubTator, text mining | PubMed |
| Advances in covalent drug discovery. | Nat Rev Drug Discov | 2022 | 36008483 | PubTator, text mining | PubMed |
| Marine Natural Products in Clinical Use. | Mar Drugs | 2022 | 36005531 | PubTator, text mining | PubMed |
| Preclinical evaluation of proteolytic targeting of LCK as a therapeutic approach in T cell acute lymphoblastic leukemia. | Sci Transl Med | 2022 | 36001679 | PubTator, text mining | PubMed |
| Patent landscape of inhibitors and PROTACs of the anti-apoptotic BCL-2 family proteins. | Expert Opin Ther Pat | 2022 | 35993382 | PubTator, text mining | PubMed |
| Key Considerations in Targeted Protein Degradation Drug Discovery and Development. | Front Chem | 2022 | 35978859 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of potent FAK-degrading PROTACs. | J Enzyme Inhib Med Chem | 2022 | 35978496 | PubTator, text mining | PubMed |
| Multiple Myeloma: Bioinformatic Analysis for Identification of Key Genes and Pathways. | Bioinform Biol Insights | 2022 | 35958298 | PubTator, text mining | PubMed |
| PARP Inhibitors: Clinical Limitations and Recent Attempts to Overcome Them. | Int J Mol Sci | 2022 | 35955544 | PubTator, text mining | PubMed |
| Targeting Protein Degradation Pathways in Tumors: Focusing on their Role in Hematological Malignancies. | Cancers (Basel) | 2022 | 35954440 | PubTator, text mining | PubMed |
| Discovery of a Highly Potent and Selective Dual PROTAC Degrader of CDK12 and CDK13. | J Med Chem | 2022 | 35938508 | PubTator, text mining | PubMed |
| Chemical inhibitors of transcription-associated kinases. | Curr Opin Chem Biol | 2022 | 35926294 | PubTator, text mining | PubMed |
| Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission. | Haematologica | 2022 | 35924576 | PubTator, text mining | PubMed |
| ERK5 Signalling and Resistance to ERK1/2 Pathway Therapeutics: The Path Less Travelled? | Front Cell Dev Biol | 2022 | 35903549 | PubTator, text mining | PubMed |
| Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough. | J Clin Invest | 2022 | 35900863 | PubTator, text mining | PubMed |
| Emerging Therapies in Cutaneous Lupus Erythematosus. | Front Med (Lausanne) | 2022 | 35899214 | PubTator, text mining | PubMed |
| A case of chronic neutrophilic leukemia and multiple myeloma showing the benefits of lenalidomide and cyclophosphamide therapy in treating both conditions. | Am J Hematol | 2022 | 35898175 | PubTator, text mining | PubMed |
| Discovery of a First-in-Class Degrader for Nuclear Receptor Binding SET Domain Protein 2 (NSD2) and Ikaros/Aiolos. | J Med Chem | 2022 | 35895319 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=55